Marcia K Liepman - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

AJNR. American Journal of Neuroradiology|October 13, 2005

Oligodendroglioma metastatic to bone marrowFiras Al-Ali, Aaron J Hendon, Marcia K Liepman, et al.

Gynecologic Oncology|November 1, 2011

A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group studyAgustin A Garcia, Michael W Sill, Heather A Lankes, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227Jon Glass, Minhee Won, Christopher J Schultz, et al.

Clinical Breast Cancer|June 21, 2011

Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research GroupPriya Rastogi, Marc E Buyse, Sandra M Swain, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

AJNR. American Journal of Neuroradiology|October 13, 2005

Oligodendroglioma metastatic to bone marrowFiras Al-Ali, Aaron J Hendon, Marcia K Liepman, et al.

Gynecologic Oncology|November 1, 2011

A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group studyAgustin A Garcia, Michael W Sill, Heather A Lankes, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227Jon Glass, Minhee Won, Christopher J Schultz, et al.

Clinical Breast Cancer|June 21, 2011

Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research GroupPriya Rastogi, Marc E Buyse, Sandra M Swain, et al.

Pageof 1